Perspective Therapeutics
CATX
30 hedge funds and large institutions have $2.6M invested in Perspective Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
20% more funds holding
Funds holding: 25 → 30 (+5)
0.08% more ownership
Funds ownership: 0.74% → 0.81% (+0.08%)
11% less capital invested
Capital invested by funds: $2.92M → $2.6M (-$321K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$248K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$55.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$16.6K |
| 4 |
PCM
Pointe Capital Management
Grosse Pointe Farms,
Michigan
|
+$13K |
| 5 |
TA
TMD & Associates
Scottsdale,
Arizona
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.1K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$28.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17.1K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$8K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FANJ
26
Financial Architects (New Jersey)
Marlton,
New Jersey
| $3K | – | – | – |
|
|
JFA
27
JNBA Financial Advisors
Bloomington,
Minnesota
| $3K | +$3.06K | +500 | New |
|
|
SIM
28
Sonora Investment Management
Tucson,
Arizona
| $2.9K | – | – | – |
|
|
29
UBS Group
Zurich,
Switzerland
| $1K | -$17.1K | -2,789 | -97% |
|
|
30
Wolverine Trading
Chicago,
Illinois
| – | -$8K | -1,140 | Closed |
|
CATX Hedge Fund Activity: Q4 2016 in Review
30 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2016, worth a combined $2.6M — down 11% from $2.92M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CATX positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $248K. The largest seller was Vanguard Group, cutting an estimated $41.1K.
- 30 institutional investors held Perspective Therapeutics (CATX) as of Q4 2016, up from 25 in Q3 2016.
- Funds reported $2.6M of Perspective Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
- 6 funds opened new Perspective Therapeutics positions in Q4 2016 and 1 closed out, a net change of +5 holders.
- The largest Perspective Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $248K added.
- The largest Perspective Therapeutics seller in Q4 2016 was Vanguard Group, an estimated $41.1K sold.
Based on aggregated 13F filings for Q4 2016.